Cobas pure integrated solutions is a new compact analyzer that combines three technologies in a single platform to simplify daily operations at labs with limited space and resources.
Roche announced the launch of cobas pure integrated solutions, a new compact analyzer that combines three technologies in a single platform to simplify daily operations at labs with limited space and resources.
With a footprint of 2 m2, the analyzer focuses on the automation of manual tasks by performing up to 870 tests per hour while providing a full clinical chemistry and immunochemistry assay menu, which includes more than 230 diagnostic tests, Roche said in a March 17, 2021 press release. Additionally, the analyzer provides fully standardized results and operation to Roche’s cobas pro, its analyzer for large labs, and is compatible with the cobas mobile solution, a tablet that allows users to interact with the analyzer from anywhere in the lab.
“During these challenging times, providing accurate and timely testing has never been more vital. Roche continues to invest heavily in laboratory innovation to help meet the changing demands of healthcare systems,” said Thomas Schinecker, CEO Roche Diagnostics, in the press release. “With the launch of cobas pure integrated solutions, we seek to simplify complex workflows in small-to-medium-sized labs so that laboratory professionals can focus on providing clinicians with the information they need to make reliable and timely clinical decisions for patients.”
Source: Roche
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.
Navigating Annex 1 for Early Phase Sterile Fill Finish in Clinical Supplies
November 21st 2024Stay compliant with Annex 1 for early phase sterile fill finish processes. Discover how to implement robust contamination control strategies, integrate isolator technology, and conduct integrity testing to meet stringent European Union standards. The guide provides a comprehensive look at key elements such as PUPSIT, critical zone controls, and monitoring and training for aseptic processes.
Your Ultimate Guide for CMC Testing Support for Gene and Cell Therapy
November 21st 2024Explore the complexities of gene and cell therapy development with our comprehensive guide to Chemistry, Manufacturing, and Controls (CMC) testing. Learn how our expertise ensures the safety, potency, and quality of advanced therapies, supporting your journey from product development through regulatory approval.